PTH and osteoporosis: Taken together, these observations suggest that intermittent PTH1-34 treatments may act as a senolytic-like drug, reducing systemic and brain inflammation, improving cognitive function, and implicating the potential therapeutic benefits of PTH1-34 for not only osteoporosis but also AD.